- Biotech and healthcare financing and deal making in a macroeconomic context – before 2020, during COVID-19, and compared to other industries
- Underlying drivers for recent trends in Biotech financing and deals - what was triggered/changed vs. accelerated through COVID-19?
- What does it mean for the year ahead?
- How will this play out considering several potential economy scenarios? What swing factors can impact this further
Jorge Santos da Silva, Partner, McKinsey & Company
This session was delivered as part of the Investival Showcase 2020. Find out about the full event by downloading the brochure.